NO980095L - Nye quinoxalin- og quinoxalinylalkan-forfonsyrer - Google Patents
Nye quinoxalin- og quinoxalinylalkan-forfonsyrerInfo
- Publication number
- NO980095L NO980095L NO980095A NO980095A NO980095L NO 980095 L NO980095 L NO 980095L NO 980095 A NO980095 A NO 980095A NO 980095 A NO980095 A NO 980095A NO 980095 L NO980095 L NO 980095L
- Authority
- NO
- Norway
- Prior art keywords
- free
- quinoxalinyl
- esterified
- alkane
- aliphatic
- Prior art date
Links
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 title abstract 4
- -1 quinoxalinyl alkane Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000003396 thiol group Chemical class [H]S* 0.000 abstract 2
- IVHVNMLJNASKHW-UHFFFAOYSA-M Chlorphonium chloride Chemical compound [Cl-].CCCC[P+](CCCC)(CCCC)CC1=CC=C(Cl)C=C1Cl IVHVNMLJNASKHW-UHFFFAOYSA-M 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 230000003042 antagnostic effect Effects 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH200995 | 1995-07-10 | ||
| PCT/EP1996/002866 WO1997003079A1 (fr) | 1995-07-10 | 1996-07-01 | Nouveaux acides quinoxaline- et quinoxalinylalkane-phosphoniques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO980095D0 NO980095D0 (no) | 1998-01-09 |
| NO980095L true NO980095L (no) | 1998-03-05 |
Family
ID=4223780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO980095A NO980095L (no) | 1995-07-10 | 1998-01-09 | Nye quinoxalin- og quinoxalinylalkan-forfonsyrer |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0837864A1 (fr) |
| JP (1) | JPH11508902A (fr) |
| KR (1) | KR19990028839A (fr) |
| AU (1) | AU6516296A (fr) |
| BR (1) | BR9609644A (fr) |
| CA (1) | CA2224718A1 (fr) |
| CZ (1) | CZ5398A3 (fr) |
| HU (1) | HUP9901345A3 (fr) |
| IL (1) | IL122872A0 (fr) |
| NO (1) | NO980095L (fr) |
| PL (1) | PL324340A1 (fr) |
| SK (1) | SK2798A3 (fr) |
| TR (1) | TR199800022T1 (fr) |
| WO (1) | WO1997003079A1 (fr) |
| ZA (1) | ZA965800B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2264171T3 (es) * | 1996-10-24 | 2006-12-16 | Novartis Ag | Acidos aminoalcanofosfonicos sustituidos. |
| US6841684B2 (en) | 1997-12-04 | 2005-01-11 | Allergan, Inc. | Imidiazoles having reduced side effects |
| US6329369B1 (en) | 1997-12-04 | 2001-12-11 | Allergan Sales, Inc. | Methods of treating pain and other conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5118675A (en) * | 1991-02-15 | 1992-06-02 | American Home Products Corporation | Quinoxaline phosphono-amino acids |
| IL109397A0 (en) * | 1993-04-28 | 1994-07-31 | Schering Ag | Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1996
- 1996-07-01 PL PL96324340A patent/PL324340A1/xx unknown
- 1996-07-01 BR BR9609644A patent/BR9609644A/pt not_active Application Discontinuation
- 1996-07-01 CZ CZ9853A patent/CZ5398A3/cs unknown
- 1996-07-01 CA CA002224718A patent/CA2224718A1/fr not_active Abandoned
- 1996-07-01 TR TR1998/00022T patent/TR199800022T1/xx unknown
- 1996-07-01 WO PCT/EP1996/002866 patent/WO1997003079A1/fr not_active Application Discontinuation
- 1996-07-01 SK SK27-98A patent/SK2798A3/sk unknown
- 1996-07-01 IL IL12287296A patent/IL122872A0/xx unknown
- 1996-07-01 AU AU65162/96A patent/AU6516296A/en not_active Abandoned
- 1996-07-01 JP JP9505465A patent/JPH11508902A/ja active Pending
- 1996-07-01 KR KR1019980700140A patent/KR19990028839A/ko not_active Application Discontinuation
- 1996-07-01 HU HU9901345A patent/HUP9901345A3/hu unknown
- 1996-07-01 EP EP96924829A patent/EP0837864A1/fr not_active Withdrawn
- 1996-07-09 ZA ZA965800A patent/ZA965800B/xx unknown
-
1998
- 1998-01-09 NO NO980095A patent/NO980095L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK2798A3 (en) | 1998-07-08 |
| NO980095D0 (no) | 1998-01-09 |
| IL122872A0 (en) | 1998-08-16 |
| JPH11508902A (ja) | 1999-08-03 |
| TR199800022T1 (xx) | 1998-05-21 |
| CA2224718A1 (fr) | 1997-01-30 |
| MX9800332A (es) | 1998-07-31 |
| KR19990028839A (ko) | 1999-04-15 |
| AU6516296A (en) | 1997-02-10 |
| HUP9901345A2 (hu) | 1999-08-30 |
| PL324340A1 (en) | 1998-05-25 |
| CZ5398A3 (cs) | 1998-06-17 |
| WO1997003079A1 (fr) | 1997-01-30 |
| BR9609644A (pt) | 1999-05-11 |
| ZA965800B (en) | 1997-01-10 |
| HUP9901345A3 (en) | 2000-01-28 |
| EP0837864A1 (fr) | 1998-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID21927A (id) | Asam aminoalkanafosfonat tersubstitusi | |
| MY103021A (en) | Fluoroalkoxy substituted benzimidazoles useful as gastric acid secretion inhibitors | |
| ATE233256T1 (de) | 2-pyrimidinamin derivaten und verfahrens zu deren herstellung | |
| BG49940A3 (en) | Method for preparing derivatives of 4- (4- phenyl- 1- piperazinile)- phenols | |
| DK0526488T3 (da) | Benzylphosphonsyre-tyrosinkinaseinhibitorer | |
| DK0863875T3 (da) | Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser | |
| ATE168101T1 (de) | Arylpyridazinone | |
| NO864474D0 (no) | Nye 4-benzyl-1-(2h)-ftalazinon-derivater. | |
| EP0175250A3 (en) | Agent and process for the determination of redox systems | |
| NO955326L (no) | Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse | |
| BR0005005A (pt) | Aditivo de polìmero para um meio de banho alcalino de eletrogalvanização de zinco ou liga de zinco, meio de banho alcalino de zinco ou liga de zinco, processo para eletrogalvanizar zinco e/ou ligas de zinco em um substrato condutivo, e uso do polìmero | |
| DE69717091D1 (de) | Oxazole derivate,ihre herstellung und verwendung | |
| NO980095L (no) | Nye quinoxalin- og quinoxalinylalkan-forfonsyrer | |
| MD383C2 (ro) | Procedeu de obţinere a piperazinilalchil-3(2H)-piridazinonelor sau sărurilor lor farmaceutic admisibile | |
| PL335839A1 (en) | Cycloalkylalkane carboxamides as well as their production and application | |
| ES8800122A1 (es) | Un procedimiento para la preparacion de derivados de indeno y naftaleno. | |
| DK227085D0 (da) | 1-halogen-1-azolyl-2,2-diaryl-ethan-derivater, salte og metalkomplekser deraf samt deres fremstilling og anvendelse | |
| ES2114676T3 (es) | Derivados substituidos del acido orto-etenilfenilacetico. | |
| TR199903159T2 (xx) | Yeni �-Amino ve �-Azido karbonik asit t�revleri. | |
| EP0222578A3 (fr) | Utilisation d'analogues cycliques de la somatostatine pour le traitement des maladies d'hypersensitivité immédiate | |
| ES486050A1 (es) | Procedimiento de preparacion de ditiocarbamatos | |
| ES8702377A1 (es) | Procedimiento para la obtencion de nuevos derivados de 3- mercapto-1,2,4-triazacicloalcadieno | |
| YU46677B (sh) | Indan sulfonamidi i njihovi intermedijeri, postupak za njihovo dobijanje | |
| TH28211B (th) | อนุพันธ์ของคาร์บอกซิลิค แอซิดชนิดใหม่ การเตรียมและการใช้สารเหล่านี้ | |
| NO924221L (no) | Fremgangsmaate for behandling av en vandig pigmentsuspensjon med et vandig bindemiddel |